Itır Ebru Zemheri

9PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsCardiology (incl. cardiovascular diseases)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 23, 2026
Mismatch Repair Deficiency and Programmed Death-Ligand 1 Expression in Treatment-Naïve High-Risk and Very High-Risk Locally Advanced Prostate Cancer: Histomorphological Associations and Prognostic Value.

|Oct 30, 2024
Delivery of BikDD proapoptotic gene in Peptide-18-targeted Poly(2-oxazoline)-DOPE nanoliposomes for breast cancer models.

Zeynep Büşra Bolat, Ayça Ece Nezir, Ongun Mehmet Saka

|Oct 08, 2024
Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis

Hakan Keski, Selim Merdan, Itır Ebru Zemheri

|Jul 25, 2024
PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted BikDDA delivery to prostate cancer.

Ayca Ece Nezir, Zeynep Büşra Bolat, Ongun Mehmet Saka

|Jun 15, 2023
Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers.

Ayca Ece Nezir, Zeynep Busra Bolat, Naile Ozturk

|Mar 14, 2022
Calretinin immunohistochemical staining in Hirschsprung's disease: An institutional experience.

Ebru Zemheri, Pinar Engin Zerk, Cigdem Ulukaya Durakbasa

Pageof 2

Frequent Collaborators

3 joint publications

Umut Ugur Ozkose

3 joint publications

Fikrettin Sahin

3 joint publications

Ozgur Yilmaz

3 joint publications

Sevgi Gulyuz